Fresh analysis indicates that people who stop using new weight-loss injections like semaglutide or tirzepatide tend to recover reduced body mass much more quickly than those who halt traditional diet and exercise plans.
Research printed in a prominent medical journal demonstrates that while obese people often shed substantial amounts of their total mass while undergoing treatment, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.
"People buying these treatments need to be cognizant of the danger of quick weight regain when the medication concludes," warns lead investigator Dr. Susan Jebb.
That rate of recovery suggests a return to original weight in about one and a half years.
Weighing Treatments
The research, which looked at dozens of trials involving over 9,000 of patients, compared the effects of the injectable medications with older methods.
The team note that individuals who shed pounds through dieting generally see a less rapid creep back—approximately 100 grams monthly—once they finish.
Understanding the Rapid Regain
Doctors suggest the way of the drugs is key to understanding the heightened regain.
The injections imitate a body's own chemical called GLP-1, which helps regulate appetite.
"Sustained high doses of the hormone concentrations several times higher than normal could lead to the body to generate a reduced amount of its own natural hormone, and may also diminish responsiveness to its actions," noted Dr. Adam Collins, a dietetics researcher.
"Withdrawal of this GLP-1 'fix' results in appetite is uncontrolled, making binge eating a significant risk."
A Chronic Condition?
Health authorities recommend the injections for individuals with weight-linked medical conditions, accompanied by recommended lifestyle changes.
Professionals argue that, considering the high risk of relapse, the treatment is often long-term.
This view is reinforced by drug manufacturers, who say that the findings "highlight the chronic character of obesity," akin to managing diseases like high blood pressure.
Patient Experiences
Users who have stopped the jabs explain a powerful return of cravings.
"I experienced a switch activating and you're instantly starving," described an individual.
This challenge is exacerbated if users have not established lasting lifestyle or habit changes during therapy.
Widespread Adoption
Survey data show that millions of people in the UK have used weight-loss jabs in the past year, with interest remaining high.
- Adoption is more common among women compared to males.
- The middle-aged age group shows the highest level of interest.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, experts emphasize that while these medications are powerful agents for shedding pounds, they are not a standalone cure and maintained weight loss relies on ongoing lifestyle support.
